Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2008
Src as a potential therapeutic target in non-small-cell lung cancerG Giaccone, P A Zucali
European Review for Medical and Pharmacological Sciences|July 20, 2022
An Italian survey on the use of denosumab for the management of skeletal-related events in patients with bone metastasesR Berardi, A Berruti, L Brogelli, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 30, 2015
Role of chemotherapy in combination with hormonal therapy in first-line treatment of metastatic hormone-sensitive prostate cancerG L Ceresoli, F De Vincenzo, M G Sauta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Irinotecan and raltitrexed: an active combination in advanced colorectal cancerC Carnaghi, L Rimassa, I Garassino, et al.
Cancer Treatment Reviews|February 4, 2011
Advances in the biology of malignant pleural mesotheliomaP A Zucali, G L Ceresoli, F De Vincenzo, et al.
British Journal of Cancer|June 10, 2004
Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancerH S Parra, R Cavina, F Latteri, et al.
Lung Cancer (Amsterdam, Netherlands)|December 11, 2013
Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesotheliomaP A Zucali, M Perrino, E Lorenzi, et al.
Lung Cancer (Amsterdam, Netherlands)|December 31, 2005
EGFR overexpression in malignant pleural mesothelioma. An immunohistochemical and molecular study with clinico-pathological correlationsA Destro, G L Ceresoli, M Falleni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Activity of a specific inhibitor, gefitinib (Iressa, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancerA Santoro, R Cavina, F Latteri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2008
Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitorsP A Zucali, M G Ruiz, E Giovannetti, et al.
Pageof 3